Current management of cervical cancer in women living with HIV

Evelyn Lilian Beas-Lozano,Sergio Contreras,Maria Andrea Mac Donald-Jaramillo,Citlali Frayde-Aguilar,Javier Carrillo-Vidales,Salvador Jaime-Casas,Bertha Alejandra Martinez-Cannon
DOI: https://doi.org/10.1016/j.critrevonc.2024.104519
2024-09-24
Abstract:Cervical cancer is a significant global health issue, particularly in low- and middle-income countries. Women living with HIV (WLWH) are not only at higher risk of cervical cancer due to their increased susceptibility to high-risk human papillomavirus (HPV) infection and compromised immune status, but also higher mortality rates have been reported. Therefore, prevention, optimal screening, use of highly active antiretroviral therapy (HAART), and early access to treatment are of utmost importance in this population. While international guidelines for cervical cancer state no treatment differences should be made for WLWH, there is evidence that this population of patients represents a challenge in decision-making for medical oncologists, radiation oncologists, and surgical oncologists. This review summarizes the available evidence on the different treatment strategies for WLWH and invasive cervical cancer and highlights the need for special considerations in screening andprevention of cervical cancer in WLWH.
What problem does this paper attempt to address?